Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants

Eiji Shimizu, Kenji Hashimoto, Naoe Okamura, +8

Biological Psychiatry

PsychiatryMood SymptomSubcortical Ischemic DepressionDepressionSchizophrenia +12

Neuropeptide S-Mediated Control of Fear Expression and Extinction: Role of Intercalated GABAergic Neurons in the Amygdala

Kay Jüngling, Thomas Seidenbecher, Ludmila Sosulina, +8

Neuron

Neurobiological MechanismBehavioral SciencesNeuropeptidesNeuroanatomyAffective Neuroscience +8

Pharmacological Characterization of Human and Murine Neuropeptide S Receptor Variants

Rainer K. Reinscheid, Yanling Xu, Naoe Okamura, +5

Journal of Pharmacology and Experimental Therapeutics

Decreased levels of serum brain-derived neurotrophic factor in female patients with eating disorders

Michiko Nakazato, Kenji Hashimoto, Eiji Shimizu, +6

Biological Psychiatry

NutritionBody CompositionAppetite ControlPsychiatryEating Disorders +8

Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls

Eiji Shimizu, Kenji Hashimoto, Hiroyuki Watanabe, +8

Neuroscience Letters

Neuroimaging BiomarkersPsychiatrySchizophreniaNeuropsychiatryNeuroimaging +5

Effect of antioxidant N-acetyl-l-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine

Goro Fukami, Kenji Hashimoto, Kaori Koike, +3

Brain Research

Behavioral ChangesPsychoactive DrugAddictionMedicinePsychopharmacology +8

Gender-specific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder

Naoe Okamura, Kenji Hashimoto, Masaomi Iyo, +4

Progress in Neuro-Psychopharmacology and Biological Psychiatry

PsychiatryBehavioral NeurosciencePsychotic DisorderPsychiatric GeneticsPsychology +12

Tropisetron improves deficits in auditory P50 suppression in schizophrenia

Kaori Koike, Kenji Hashimoto, N Takai, +8

Schizophrenia Research

PsychiatryPsychotropic MedicationAuditory P50 SuppressionSchizophreniaNeuropharmacology +4

Neuropeptide S Enhances Memory During the Consolidation Phase and Interacts with Noradrenergic Systems in the Brain

Naoe Okamura, Celia Garau, Dee M. Duangdao, +4

Neuropsychopharmacology

Cognitive ScienceNoradrenergic SystemsNeurophysiologyMedicineNeurotransmitter +8

Synthesis and Pharmacological in Vitro and in Vivo Profile of 3-Oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic Acid 4-Fluoro-benzylamide (SHA 68), a Selective Antagonist of the Neuropeptide S Receptor

Naoe Okamura, Stephen A. Habay, Joanne Zeng, +2

Journal of Pharmacology and Experimental Therapeutics